XML 36 R26.htm IDEA: XBRL DOCUMENT v3.8.0.1
REVENUE RECOGNITION AND RELATED ALLOWANCES (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Revenue Recognition $ 46,483 $ 36,628
Sales of generic pharmaceutical products [Member]    
Revenue Recognition 23,227 26,572
Sales of branded pharmaceutical products [Member]    
Revenue Recognition 16,595 8,039
Sales of contract manufactured products [Member]    
Revenue Recognition 945 1,793
Royalties on sales of pharmaceutical products [Member]    
Revenue Recognition 5,382 0
Other [Member]    
Revenue Recognition [1] $ 334 $ 224
[1] Primarily includes laboratory services and royalties on sales of contract manufactured products